Results 271 to 280 of about 91,224 (305)
Some of the next articles are maybe not open access.

Identification of predictive markers and outcomes of late-onset Pneumocystis jirovecii pneumonia in kidney transplant recipients.

Clinical Infectious Diseases, 2020
BACKGROUND In the era of prophylaxis, Pneumocystis pneumonia has become a late-onset opportunistic infection requiring indications for prolonged prophylaxis to be defined.
H. Kaminski   +14 more
semanticscholar   +1 more source

Pneumocystis Infection Outbreaks in Organ Transplantation Units in France: A Nation-Wide Survey.

Clinical Infectious Diseases, 2020
The burden of nosocomial Pneumocystis infections in transplantation units in France was evaluated through a retrospective survey. Over 12 years, 16 outbreaks occurred, including 13 among renal transplant recipients (RTRs).
S. Gal   +32 more
semanticscholar   +1 more source

Pneumocystis Pneumonia

Seminars in Respiratory and Critical Care Medicine, 2011
Pneumocystis (carinii) jiroveci pneumonia can occur in immunocompromised individuals, especially hematopoietic stem and solid organ transplant recipients and those receiving immunosuppressive agents, and is the most common opportunistic infection in persons with advanced human immunodeficiency virus (HIV) infection. The Pneumocystis genus was initially
Shelley A, Gilroy, Nicholas J, Bennett
openaire   +2 more sources

Pneumocystis carinii

Clinics in Chest Medicine, 1988
This article covers the biology, epidemiology, and pathology of infection with Pneumocystis carinii. The clinical presentation, course, and treatment of pneumonia caused by this organism in patients infected with the human immunodeficiency virus is discussed.
S J, Levine, D A, White
openaire   +2 more sources

Pneumocystis carinii pneumonia: the status of Pneumocystis biochemistry

International Journal for Parasitology, 1998
Pneumocystis carinii pneumonia remains a prevalent opportunistic disease among immunocompromised individuals. Although aggressive prophylaxis has decreased the number of acute P. carinii pneumonia cases, many patients cannot tolerate the available drugs, and experience recurrence of the infection, which can be fatal. It is now generally agreed that the
openaire   +3 more sources

Pneumocystis jirovecii

2010
The ascomycete fungus Pneumocystis jirovecii (previously called Pneumocystis carinii) is the cause of pneumocystis pneumonia (PCP) in humans, which occurs largely among people with impaired CD4+ T-lymphocyte function or numbers, e.g those infected with HIV, or organ transplant recipients taking therapeutic immunosuppressive agents.
Robert F. Miller, Laurence Huang
openaire   +1 more source

The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome.

American Review of Respiratory Disease, 2015
Thirty-two patients with or suspected of having the acquired immunodeficiency syndrome were evaluated for opportunistic lung infection using examination of sputum induced by inhalation of 3% saline.
Bigby Td   +6 more
semanticscholar   +1 more source

The association between Cytomegalovirus co‐infection with Pneumocystis pneumonia and mortality in immunocompromised non‐HIV patients

Clinical Respiratory Journal, 2018
Impact of Cytomegalovirus (CMV) co‐infection pneumonia in non‐HIV patients with Pneumocystis jirovecii pneumonia (PCP) is unclear.
P. Korkmaz Ekren   +10 more
semanticscholar   +1 more source

Pneumocystis carinii Pneumonitis

Infectious Diseases in Clinical Practice, 1984
I n a sense, opportunistic infections may serve as diagnostic indicators of certain host defects or disease processes that diminish the immune response. The myriad microbes comprising the endogenous and exogenous flora of man are rarely a threat to the health of normal individuals.
openaire   +7 more sources

Pneumocystis jirovecii Pneumonia

Infectious Disease Clinics of North America, 2010
Pneumocystis jirovecii has gained attention during the last decade in the context of the AIDS epidemic and the increasing use of cytotoxic and immunosuppressive therapies. This article summarizes current knowledge on biology, pathophysiology, epidemiology, diagnosis, prevention, and treatment of pulmonary P jirovecii infection, with a particular focus ...
Louis-Jean Couderc   +6 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy